Immunogen (IMGN) Competitor Comparison
We are evaluating the key criteria listed to compare Immunogen (IMGN) against its competitors in the Biotechnology industry.
Market Capitalization
20 / 368Gross Profits
239 / 278Total Revenue
42 / 300EBITDA
175 / 337Free Cashflow
305 / 352Quick Ratio
171 / 357Earnings per Share
66 / 359Dividend yield
0 / 6Total Cash
47 / 358Performance 3 years
22 / 368Performance 5 years
19 / 368Performance 10 years
63 / 368Linearity 3 years
359 / 368Linearity 5 years
353 / 368Linearity 10 years
332 / 368Total Rank
155 / 368Dividend Rank
159 / 368Valuation Rank
159 / 368Piotroski Rank
290 / 368Muliplier Rank
364 / 368Total Cash - IMGN ranking 47 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.